Ftse Mib
38.332,30
1,68%
DAX
22.790,40
2,12%
S&P 500
5.572,07
-0,76%
NASDAQ
17.436,10
0,00%
Bitcoin
82.853,91
0,01%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NeoGenomics Inc (NEO) NeoGenomics Inc (NEO) Notizie

NeoGenomics Inc

NEO
10,90
0,02 (0,18%)
Pre Mercato
Ultimo aggiornamento: 11:21:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/2/202522:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/2/202522:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/2/202522:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/2/202522:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/2/202522:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202513:05BWNeoGenomics to Participate in Upcoming Investor Conferences
18/2/202522:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
18/2/202513:08EDGAR2Form 8-K - Current report
18/2/202513:05BWNeoGenomics Reports Fourth Quarter and Full Year 2024..
14/2/202517:35EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
30/1/202515:05GLOBEPacBio Announces Appointment of Chris Smith to Board of..
29/1/202514:05BWNeoGenomics to Report Fourth Quarter and Full Year 2024..
16/1/202522:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202522:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202522:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202522:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202513:26EDGAR2Form 8-K - Current report
15/1/202513:05BWNeoGenomics Provides 2025 Financial Guidance and Updates..
14/1/202513:30GLOBEAdaptive Biotechnologies and NeoGenomics Partner to Expand..
10/1/202513:05EDGAR2Form 8-K - Current report
10/1/202513:05BWNeoGenomics Announces Chief Executive Officer Succession
06/1/202513:55BWNeoGenomics to Participate in the 43rd Annual J.P. Morgan..
11/12/202414:05BWNeoGenomics’ Newly Published Study Underscores Potential of..
10/12/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202414:10BWNeoGenomics to Present Key Research on Hematologic..
04/12/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202414:15BWNeoGenomics to Present New Data at AMP 2024, Highlighting..
15/11/202422:35EDGAR2Form 144 - Report of proposed sale of securities
14/11/202419:28EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202414:10BWFelicia Williams Joins NeoGenomics Board of Directors
08/11/202413:00BWNeoGenomics to Participate in the Piper Sandler 36th Annual..
05/11/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202413:14EDGAR2Form 8-K - Current report
05/11/202413:00BWNeoGenomics Reports Third Quarter 2024 Results
22/10/202414:10BWNeoGenomics Receives New York State Approval for Neo..
15/10/202413:30BWNeoGenomics to Report Third Quarter 2024 Financial Results..
08/10/202414:10BWNeoGenomics Launches AML Express for Rapid Genetic Profiling..
24/9/202400:47BWNeoGenomics Announces New RaDaR Technology and Resolution of..
11/9/202414:05BWNeoGenomics to Present New Data at ESMO 2024, Highlighting..
04/9/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202414:05BWNeoGenomics to Participate in the Morgan Stanley 22nd Annual..
19/8/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:29EDGAR2Form 144 - Report of proposed sale of securities
15/8/202422:12EDGAR2Form 144 - Report of proposed sale of securities
13/8/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 10,88

La tua Cronologia

NASDAQ
NEO
NeoGenomics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci